logo
Select company
Select metric
$ -37.34MEarning Before Interest & Taxes (EBIT)
VS
Market
19
Sector
42
Industry
56
History
-
$ 0.62Close
$ 0.36 - $ 4.96 52-Week Range
Ticker Information

Ticker

IBO

Company Name

IMPACT BIOMEDICAL INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

IMPACT BIOMEDICAL INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IBO - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -37.34M
3/31/2025$ -23.88M
12/31/2024$ -23.61M
9/30/2024$ 2.08M
6/30/2024$ -3.53M
3/31/2024$ -3.89M
12/31/2023$ -3.89M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IMPACT BIOMEDICAL INC's latest trailing twelve months (TTM) EBIT stands at $ -3.89M.
  • Over the past 5 years, IMPACT BIOMEDICAL INC's average EBIT has been $ -13.44M.
  • The median EBIT for IMPACT BIOMEDICAL INC during this period was $ -3.89M
  • IMPACT BIOMEDICAL INC reached its highest EBIT over the past 5 years at $ 2.08M.
  • The lowest EBIT recorded by IMPACT BIOMEDICAL INC in the same timeframe $ -37.34M

IMPACT BIOMEDICAL INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
CELZ : CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC $ -5.77MTCRT : ALAUNOS THERAPEUTICS INC $ -3.99MADTX : ADITXT INC $ -30.23MHSCS : HEARTSCIENCES INC $ -8.11MPMCB : PHARMACYTE BIOTECH INC $ -1.13MAPVO : APTEVO THERAPEUTICS INC $ -24.02MPALI : PALISADE BIO INC $ -11.83MACXP : ACURX PHARMACEUTICALS INC $ -10MGNPX : GENPREX INC $ -17.29MTTNP : TITAN PHARMACEUTICALS INC $ -2.81M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

IBO - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -37.34M

Minimum

Jun 30, 2025

$ 2.08M

Maximum

Sep 30, 2024

$ -13.44M

Average

$ -3.89M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.81M with a standard deviation of $ 130.86M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 443M
average$ 28.81M
median$ 1.05M
std$ 130.86M